Prediction Case File
YouTubeTracking Live

This Stock Reminds Me of AMD in 2025

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
02 Sept 2026, 18:23 UTC
Recorded by Tahlil Plus
02 Sept 2026, 20:12 UTC
Video preview for This Stock Reminds Me of AMD in 2025
Source overview

AI-generated source summary

The analysis focuses on QUALCOMM (QCOM), identifying a significant opportunity for growth driven by their AI accelerator technology and the increasing demand in data centers. Despite a recent earnings report showing a 4% year-over-year decline in revenue, primarily due to a 20% drop in handset chip sales, the company's automotive and IoT segments showed strong growth of 61% and 9% respectively. The core thesis is that QUALCOMM's non-handset revenue, particularly from the data center segment, is projected to accelerate significantly, with forecasts indicating a rise from 24% in FY26 to 60%+ in FY27. Analysts suggest that this growth could offset the decline in handset revenue, with a target of non-handset revenue replacing total Apple product revenues in FY26 and expanding to $15B+ by FY29. The company's strategy involves leveraging its advanced High Bandwidth Compute (HBC) technology, which offers superior performance per watt and lower energy consumption compared to High Bandwidth Memory (HBM). This technology is being deployed in AI infrastructure and is expected to drive significant improvements in cost and performance. The stock is currently trading at a forward P/E of approximately 18x, which is considered reasonable given the growth prospects. The analysis estimates a potential upside of roughly 100% over the next three years, projecting earnings per share to exceed $18 in FY29. The current market sentiment appears to be underestimating QUALCOMM's potential in the data center and AI space, creating a potentially undervalued investment opportunity.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.2
Tracked signals
329
Historical success
33.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail